Heart & Metabolic Health - Know your numbers
Insulin resistance and blood sugar
Last updated 30 September 2026. How we write this .
Insulin resistance means tissues respond less effectively to insulin. Blood sugar may stay normal at first, then rise if the pancreas can no longer compensate.
Start here Insulin resistance means tissues respond less effectively to insulin. Blood sugar may stay normal at first, then rise if the pancreas can no longer compensate.
By the end, you will understand What insulin normally does How insulin resistance develops What changes risk Where this information comes from Claim-cited evidence. Central research claims on this lesson are linked to specific studies or official guidance.
This lesson links the specific studies and guidance used for its central claims.
Our standard: expert or athlete opinion may illustrate a viewpoint, but it is never treated as proof. Read the editorial policy .
Report an error or outdated claim .
Insulin resistance means that tissues respond less effectively to insulin, the hormone that helps regulate blood glucose. The pancreas may initially make more insulin to keep glucose controlled. If that compensation becomes insufficient, glucose can rise and the risk of type 2 diabetes increases, although progression is not inevitable.
What insulin normally does
Glucose is a fuel carried in the blood. It comes from digested carbohydrate and from the liver, which releases stored glucose and makes new glucose between meals. Blood sugar therefore reflects both incoming food and the body's own fuel supply.
Insulin is released by beta cells in the pancreas. It helps muscle and fat cells take up glucose and signals the liver to reduce glucose production. It also supports energy storage and restrains the release of fatty acids from fat tissue. These are normal functions, not signs that insulin is harmful.
Blood glucose usually rises after a meal and falls as glucose is used or stored. A rise alone does not establish a problem. Its size, duration and clinical context matter, and healthy glucose regulation does not require a completely flat line.
How insulin resistance develops
Insulin resistance is not one blocked switch. In muscle, insulin may become less effective at stimulating glucose uptake. In the liver, it may become less effective at suppressing glucose production. In fat tissue, weaker insulin action can allow more fatty acids to enter the circulation.
These changes can reinforce one another. Fat accumulating in the liver and muscle can generate molecules that interfere with insulin signalling. Inflammation and altered communication between organs can also contribute. Human physiology studies support these mechanisms, while some finer molecular explanations still rely heavily on cell and animal research.
The pancreas often compensates by releasing more insulin. This explains why someone can have insulin resistance while their glucose remains within the usual range. Higher glucose becomes apparent when insulin production is no longer sufficient for the body's needs; beta-cell function matters as well as insulin sensitivity.
It is misleading to describe this simply as a pancreas that has been 'worn out' by sugar. Genetic susceptibility, tissue biology and metabolic stress all influence beta-cell function. Insulin resistance and reduced insulin production can develop together in different proportions.
What changes risk
Body-fat distribution matters as well as total body fat. Fat stored around abdominal organs and in the liver is associated with greater metabolic risk. People differ in how readily they store fat in these locations, so body size alone cannot establish whether someone has insulin resistance.
Genetics and family history influence both insulin sensitivity and the pancreas's ability to compensate. Physical activity affects glucose use, while muscle provides a major site for glucose uptake and storage. Sleep disruption, some medicines and certain endocrine conditions can alter glucose regulation. Dietary pattern and long-term energy balance influence body fat, liver fat and metabolic demand. Muscle contractions can increase glucose uptake through pathways that do not depend entirely on insulin. This helps explain why activity can improve glucose handling before large changes in body weight occur. Muscle mass matters, but the metabolic activity of that muscle matters too.
Short experimental studies show that sleep restriction can impair insulin sensitivity. Observational studies also link poor sleep with diabetes risk, but cannot fully separate sleep from shift work, stress and other influences. Risk is therefore not a simple measure of willpower or personal discipline.
What the evidence actually shows
Large randomised trials in adults at increased risk of type 2 diabetes show that supported programmes combining dietary changes, physical activity and weight management can reduce or delay progression. NICE's guidance on type 2 diabetes prevention draws on this evidence. It does not establish that one food or exercise habit accounts for the whole benefit.
Exercise trials support improvements in insulin sensitivity and glucose regulation, although results vary with the participants and the activity studied. Some improvements occur without substantial weight loss. Studies measuring glucose over a few weeks answer a narrower question than trials tracking diabetes diagnoses over several years.
Dietary trials show that different eating patterns can improve glucose-related measures. Changes in energy intake, weight, food quality and support often happen together, making their individual contributions difficult to separate. Evidence does not establish one universally superior carbohydrate intake for everyone.
Long-term observational studies help identify risk patterns across populations, but associations cannot prove causation. Small supplement studies and laboratory findings provide much weaker grounds for claims about preventing diabetes. A plausible effect on an insulin signalling pathway is not evidence of a meaningful health benefit in people.
Normal blood glucose does not rule out insulin resistance, and an isolated high reading does not establish diabetes. Glucose regulation and a clinical diagnosis are related questions, but they are not interchangeable.
What blood tests can and cannot tell you
HbA1c measures how much glucose has attached to haemoglobin in red blood cells. It reflects glucose exposure over roughly the preceding two to three months, with more influence from recent weeks. It does not directly measure insulin resistance and can hide differences in daily glucose patterns.
Fasting glucose captures the glucose concentration at one point after a period without food. An oral glucose tolerance test examines the response to a standardised glucose challenge. These tests answer different questions, so they can disagree without either result necessarily being an error.
HbA1c can be misleading when red blood cell lifespan or haemoglobin is altered, including with some anaemias and haemoglobin variants. Pregnancy, recent blood loss and other clinical circumstances can also affect test choice or interpretation. Results need symptoms, medical history and sometimes repeat testing for context.
Fasting insulin and calculated indices are used in research and selected clinical settings, but there is no single universally accepted consumer cut-off for insulin resistance. A commercial score should not be presented as a definitive diagnosis. Clinical assessment considers the wider pattern rather than one supposedly ideal number.
Common misunderstandings and consumer devices
A continuous glucose monitor measures glucose in fluid between cells, rather than directly in blood. Readings can lag behind blood glucose and are affected by sensor limitations. These devices have established roles for some people with diabetes, but evidence that routine use improves long-term health in people without diabetes remains limited.
A lower glucose peak does not automatically mean a healthier meal. Fat can slow digestion and reduce an early rise without making a food nutritionally better. A graph does not measure fibre, overall nutrient quality or the effects of an eating pattern over years.
Likewise, tiredness after food, hunger or difficulty changing weight cannot diagnose insulin resistance. These experiences have many possible explanations. Nor does eating carbohydrate automatically cause insulin resistance: the body's response depends on the overall diet, energy balance, activity and underlying biology.
Who this applies to and when symptoms matter
This framework mainly explains insulin resistance in relation to type 2 diabetes. Type 1 diabetes involves an autoimmune loss of insulin-producing cells and cannot be understood simply as insulin resistance. Pregnancy-related glucose changes and diabetes in children also require distinct assessment rather than adult wellness assumptions.
Insulin resistance can occur in people of different body sizes and may accompany conditions such as polycystic ovary syndrome. People who already have diabetes should discuss glucose results with their care team and should not change medicines based on a consumer device.
Stop exercise or any self-directed fasting experiment if you become faint, confused or acutely unwell. Call 999 for unconsciousness, severe breathing difficulty, or possible diabetic ketoacidosis with marked thirst and frequent urination alongside vomiting, fruity-smelling breath or unusual sleepiness. See a GP if you think you may have type 2 diabetes, with symptoms such as feeling very tired, peeing more than usual, feeling thirsty all the time, losing weight without trying, blurred vision, cuts or wounds that take longer to heal, or itching around the penis or vagina or repeated thrush. Not everyone has symptoms, so see a GP if you think you are at higher risk; use NHS 111 if symptoms need urgent assessment or you are unsure where to seek help.
How to judge a claim
First identify the outcome: does the claim concern one post-meal reading, insulin sensitivity, HbA1c or future diabetes diagnoses? Then ask who was studied, whether there was a comparison group and how long follow-up lasted. Evidence from people with established diabetes may not apply to someone with normal glucose.
Credible explanations acknowledge measurement limits and variation between people. Claims that promise to 'reset' insulin, diagnose resistance from symptoms alone or rank every meal by its glucose peak go beyond the evidence. Longer-term clinical outcomes deserve more weight than impressive graphs or isolated laboratory mechanisms.
This lesson is general education, not medical advice. Seek qualified advice if you have symptoms or a medical condition, are pregnant, or take regular medicines.
Related in this classroom Related in other classrooms The studies behind this page Recommendations: identifying type 2 diabetes risk with fasting plasma glucose or HbA1c - NICE guideline PH38Sources for this classroom
Educational content only. Not medical advice, diagnosis or treatment. Always consult a qualified healthcare professional before changing your health regimen.